Ads
related to: fda
Search results
Psychedelic stocks tanked after FDA committee punted MDMA-assisted therapy for PTSD
Quartz· 6 hours agoThe stock of several companies working to develop psychedelic medicines to treat mental disorders...
FDA advisors reject MDMA therapy for PTSD, amid concerns over research
MPR News· 9 hours agoIt represents a major setback for proponents of the drug and its sponsor Lykos Therapeutics, potentially jeopardizing FDA approval of the treatment. Following public comment ...
Florida cucumbers may be linked to two separate salmonella outbreaks, FDA says
Daytona Beach News-Journal· 45 minutes agoThe FDA has been investigating any possible connections to the outbreak. "Of the 65 people...
FDA rejects MDMA drug for PTSD
WDVM via Yahoo News· 4 hours agoAn FDA panel has rejected a first-of-its kind proposal to use the psychedelic drug MDMA as a treatment for PTSD, which could have a major impact on those...
FDA concerned as whooping cough cases soar over 2023 levels
WXYZ-TV Detroit· 38 minutes agoAccording to the CDC, 4,876 cases have been reported up to week 21 of this year, compared to 1,755...
New COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panel
USA TODAY via Yahoo News· 2 hours agoVaccine manufacturers Pfizer, Moderna and Novavax each told the panel they were prepared to make...
FDA Panel to Consider Updating COVID-19 Jabs for New Virus Strains
Zacks via Yahoo Finance· 1 day agoAn FDA panel meeting is scheduled on Jun 5 to consider if COVID-19 vaccines should be updated to...
JD Supra: FDA Finalizes Rule to Assert Authority Over Laboratory Developed Tests
JD Supra· 4 hours agoThe Food and Drug Administration (FDA) published its long-awaited Final Rule that will regulate laboratory developed tests (LDTs) as in vitro diagnostic (IVD) medical devices ...
FDA panel rejects psychedelic drug MDMA as a PTSD treatment - Maryland Daily Record
The Daily Record· 6 hours agoA first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD was...
JD Supra: FDA Updates Draft Guidance on Promotional Communications of Prescription Biologics and...
JD Supra· 2 hours agoOn April 25, 2024, the FDA published a notice of availability in the Federal Register for its revised draft guidance, entitled “Promotional Labeling and Advertising Considerations ...